- Home
- RAPT vs GECC Comparison
RAPT vs GECC Comparison
Compare RAPT & GECC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAPT
- GECC
- Stock Information
- Founded
- RAPT 2015
- GECC 2016
- Country
- RAPT United States
- GECC United States
- Employees
- RAPT N/A
- GECC N/A
- Industry
- RAPT Biotechnology: Pharmaceutical Preparations
- GECC Finance: Consumer Services
- Sector
- RAPT Health Care
- GECC Finance
- Exchange
- RAPT Nasdaq
- GECC Nasdaq
- Market Cap
- RAPT 122.9M
- GECC 127.9M
- IPO Year
- RAPT 2019
- GECC N/A
- Fundamental
- Price
- RAPT $11.74
- GECC $11.09
- Analyst Decision
- RAPT Buy
- GECC
- Analyst Count
- RAPT 5
- GECC 0
- Target Price
- RAPT $33.60
- GECC N/A
- AVG Volume (30 Days)
- RAPT 105.9K
- GECC 28.5K
- Earning Date
- RAPT 08-07-2025
- GECC 08-04-2025
- Dividend Yield
- RAPT N/A
- GECC 13.80%
- EPS Growth
- RAPT N/A
- GECC 29.91
- EPS
- RAPT N/A
- GECC 1.58
- Revenue
- RAPT N/A
- GECC $47,638,000.00
- Revenue This Year
- RAPT N/A
- GECC $32.09
- Revenue Next Year
- RAPT N/A
- GECC $0.51
- P/E Ratio
- RAPT N/A
- GECC $7.00
- Revenue Growth
- RAPT N/A
- GECC 29.12
- 52 Week Low
- RAPT $5.67
- GECC $8.87
- 52 Week High
- RAPT $26.56
- GECC $11.39
- Technical
- Relative Strength Index (RSI)
- RAPT 58.44
- GECC 60.89
- Support Level
- RAPT $10.20
- GECC $10.89
- Resistance Level
- RAPT $13.50
- GECC $11.14
- Average True Range (ATR)
- RAPT 1.01
- GECC 0.09
- MACD
- RAPT -0.05
- GECC 0.00
- Stochastic Oscillator
- RAPT 77.46
- GECC 79.31
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.
About GECC Great Elm Capital Corp.
Great Elm Capital Corp is an externally managed, non-diversified closed-end management investment company. It generate both income and capital appreciation through debt and income-generating equity investments, including investments in finance businesses.